These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19424740)

  • 1. TGF-beta/extracellular matrix interactions in dentin matrix: a role in regulating sequestration and protection of bioactivity.
    Baker SM; Sugars RV; Wendel M; Smith AJ; Waddington RJ; Cooper PR; Sloan AJ
    Calcif Tissue Int; 2009 Jul; 85(1):66-74. PubMed ID: 19424740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation.
    Droguett R; Cabello-Verrugio C; Riquelme C; Brandan E
    Matrix Biol; 2006 Aug; 25(6):332-41. PubMed ID: 16766169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix proteoglycan decorin-mediated myogenic satellite cell responsiveness to transforming growth factor-beta1 during cell proliferation and differentiation Decorin and transforming growth factor-beta1 in satellite cells.
    Li X; McFarland DC; Velleman SG
    Domest Anim Endocrinol; 2008 Oct; 35(3):263-73. PubMed ID: 18650056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta1 generates a specific multicomponent extracellular matrix in human coronary SMC.
    Schmidt A; Lorkowski S; Seidler D; Breithardt G; Buddecke E
    Eur J Clin Invest; 2006 Jul; 36(7):473-82. PubMed ID: 16796604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of decorin in esophageal cancer in relation to the expression of three isoforms of transforming growth factor-beta (TGF-beta1, -beta2, and -beta3) and matrix metalloproteinase-2 activity.
    Augoff K; Grabowski K; Rabczynski J; Kolondra A; Tabola R; Sikorski AF
    Cancer Invest; 2009 May; 27(4):443-52. PubMed ID: 19212830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatopontin interacts with transforming growth factor beta and enhances its biological activity.
    Okamoto O; Fujiwara S; Abe M; Sato Y
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):537-41. PubMed ID: 9895299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen.
    Schönherr E; Broszat M; Brandan E; Bruckner P; Kresse H
    Arch Biochem Biophys; 1998 Jul; 355(2):241-8. PubMed ID: 9675033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factor effects on passaged TMJ disk cells in monolayer and pellet cultures.
    Allen KD; Athanasiou KA
    Orthod Craniofac Res; 2006 Aug; 9(3):143-52. PubMed ID: 16918679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical identification of decorin and biglycan in human dentin: a correlative field emission scanning electron microscopy/transmission electron microscopy study.
    Orsini G; Ruggeri A; Mazzoni A; Papa V; Mazzotti G; Di Lenarda R; Breschi L
    Calcif Tissue Int; 2007 Jul; 81(1):39-45. PubMed ID: 17516017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decorin binds myostatin and modulates its activity to muscle cells.
    Miura T; Kishioka Y; Wakamatsu J; Hattori A; Hennebry A; Berry CJ; Sharma M; Kambadur R; Nishimura T
    Biochem Biophys Res Commun; 2006 Feb; 340(2):675-80. PubMed ID: 16380093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1 (TGF-beta1) in dentine matrix. Ligand activation and receptor expression.
    Smith AJ; Matthews JB; Hall RC
    Eur J Oral Sci; 1998 Jan; 106 Suppl 1():179-84. PubMed ID: 9541223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.
    Hildebrand A; Romarís M; Rasmussen LM; Heinegård D; Twardzik DR; Border WA; Ruoslahti E
    Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):527-34. PubMed ID: 8093006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-localization of immunoreactive transforming growth factor-beta 1 and decorin in bronchial biopsies from asthmatic and normal subjects.
    Redington AE; Roche WR; Holgate ST; Howarth PH
    J Pathol; 1998 Dec; 186(4):410-5. PubMed ID: 10209491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of proliferation, motility, and contractivity of cultured human endometrial stromal cells by transforming growth factor-beta isoforms.
    Nasu K; Nishida M; Matsumoto H; Bing S; Inoue C; Kawano Y; Miyakawa I
    Fertil Steril; 2005 Oct; 84 Suppl 2():1114-23. PubMed ID: 16210002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of transforming growth factor-beta isoforms 1-3 in human and rabbit dentine matrices.
    Cassidy N; Fahey M; Prime SS; Smith AJ
    Arch Oral Biol; 1997 Mar; 42(3):219-23. PubMed ID: 9188992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal transforming growth factor-beta expression in mesenchymal stem cells from patients with osteoarthritis.
    Rollín R; Alvarez-Lafuente R; Marco F; García-Asenjo JA; Jover JA; Rodríguez L; López-Durán L; Fernández-Gutiérrez B
    J Rheumatol; 2008 May; 35(5):904-6. PubMed ID: 18398939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induction of transforming growth factor-beta 1 and dentin non-collagen proteins on tissue engineering pulp].
    Nie X; Jin Y; Zhang CY
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2004 Mar; 18(2):115-8. PubMed ID: 15065410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta3 induces ectopic mineralization in fetal mouse dental pulp during tooth germ development.
    Huojia M; Muraoka N; Yoshizaki K; Fukumoto S; Nakashima M; Akamine A; Nonaka K; Ohishi M
    Dev Growth Differ; 2005 Apr; 47(3):141-52. PubMed ID: 15839999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.
    Border WA; Noble NA; Yamamoto T; Harper JR; Yamaguchi Yu; Pierschbacher MD; Ruoslahti E
    Nature; 1992 Nov; 360(6402):361-4. PubMed ID: 1280332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
    Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
    Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.